Prosecution Insights
Last updated: April 19, 2026

Rein Therapeutics Inc.

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17920517 MODIFIED PEPTIDE FRAGMENTS OF CAV-1 PROTEIN AND USES THEREOF KONOPELSKI SNAVEL, SARA ELIZABETH 1658 Final Rejection Oct 21, 2022

Managing Rein Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month